Table 2 Response to high-dose imatinib... | American Society of Hematology

Table 2

Response to high-dose imatinib therapy

Response	n (%)
Complete hematologic	76 (97)
Cytogenetic
Complete	71 (91)
Major	73 (94)
Molecular
Complete	21 (27)
Major	54 (69)

Response	n (%)
Complete hematologic	76 (97)
Cytogenetic
Complete	71 (91)
Major	73 (94)
Molecular
Complete	21 (27)
Major	54 (69)

Study group N = 78. Patients were categorized by their best response.